Guselkumab is the only IL-23 inhibitor that has been proven to help stop further structural damage in patients with active psoriatic arthritis.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/guselkumab-adds-psoriatic-arthritis-structural-damage-2026a1000i12?src=rss
Author :
Publish date : 2026-05-29 17:39:00
Copyright for syndicated content belongs to the linked Source.